全文获取类型
收费全文 | 29131篇 |
免费 | 1352篇 |
国内免费 | 158篇 |
专业分类
耳鼻咽喉 | 211篇 |
儿科学 | 465篇 |
妇产科学 | 316篇 |
基础医学 | 3380篇 |
口腔科学 | 730篇 |
临床医学 | 1909篇 |
内科学 | 7073篇 |
皮肤病学 | 476篇 |
神经病学 | 2210篇 |
特种医学 | 1391篇 |
外科学 | 5512篇 |
综合类 | 124篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 923篇 |
眼科学 | 634篇 |
药学 | 2067篇 |
中国医学 | 32篇 |
肿瘤学 | 3186篇 |
出版年
2023年 | 148篇 |
2022年 | 312篇 |
2021年 | 514篇 |
2020年 | 321篇 |
2019年 | 422篇 |
2018年 | 522篇 |
2017年 | 418篇 |
2016年 | 545篇 |
2015年 | 536篇 |
2014年 | 668篇 |
2013年 | 883篇 |
2012年 | 1386篇 |
2011年 | 1563篇 |
2010年 | 911篇 |
2009年 | 797篇 |
2008年 | 1411篇 |
2007年 | 1570篇 |
2006年 | 1593篇 |
2005年 | 1530篇 |
2004年 | 1540篇 |
2003年 | 1361篇 |
2002年 | 1381篇 |
2001年 | 969篇 |
2000年 | 972篇 |
1999年 | 854篇 |
1998年 | 391篇 |
1997年 | 299篇 |
1996年 | 315篇 |
1995年 | 220篇 |
1994年 | 218篇 |
1993年 | 181篇 |
1992年 | 581篇 |
1991年 | 522篇 |
1990年 | 515篇 |
1989年 | 491篇 |
1988年 | 436篇 |
1987年 | 422篇 |
1986年 | 422篇 |
1985年 | 403篇 |
1984年 | 244篇 |
1983年 | 194篇 |
1982年 | 101篇 |
1979年 | 184篇 |
1978年 | 122篇 |
1977年 | 104篇 |
1975年 | 87篇 |
1973年 | 95篇 |
1972年 | 91篇 |
1970年 | 109篇 |
1969年 | 92篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Yujiro Nagata Takashi Kawahara Takuro Goto Satoshi Inoue Yuki Teramoto Guiyang Jiang Naohiro Fujimoto Hiroshi Miyamoto 《American journal of cancer research》2020,10(12):4386
We recently demonstrated that silodosin, a selective α1-blocker often prescribed for the symptomatic treatment of benign prostatic hyperplasia (BPH), could inactivate a c-fos proto-oncogene regulator ELK1 in bladder cancer cells possessing a functional androgen receptor (AR). However, the clinical impact of α1-blockers on the development and progression of bladder cancer remained poorly understood. In the present study, we investigated if α1-blockers clinically used, including silodosin, tamsulosin, and naftopidil, could prevent the neoplastic/malignant transformation and cell growth, using non-neoplastic urothelial SVHUC sublines with carcinogen/MCA challenge and bladder cancer lines, respectively. Bladder cancers in men treated with silodosin, tamsulosin, or naftopidil for their BPH were then compared. Silodosin at 1-10 µM significantly inhibited the neoplastic transformation of MCA-SVHUC-AR cells, but not that of AR-negative MCA-SVHUC-control cells. In MCA-SVHUC-AR, silodosin significantly reduced the expression levels of oncogenes (c-fos/NF-κB1) and induced those of tumor suppressors (p27/PTEN). However, tamsulosin (up to 1 µM) or naftopidil (up to 10 µM) failed to significantly inhibit the neoplastic transformation of AR-positive or AR-negative urothelial cells. Similarly, cell proliferation/migration of AR-positive bladder cancer lines was considerably inhibited only by silodosin. Meanwhile, the incidence of bladder cancer in patients with silodosin [49/540 (9.1%)] was marginally lower, compared to those with tamsulosin [64/523 (12.2%); P=0.094] or tamsulosin or naftopidil [64+28/523+236 (12.1%); P=0.082]. There were no significant differences in tumor grade/stage among the 3 cohorts. Outcome analysis revealed lower risks for disease progression of non-muscle-invasive bladder tumors in the silodosin group than in the naftopidil group (P=0.011) or tamsulosin+naftopidil groups (P=0.035). Similarly, silodosin patients with muscle-invasive tumor had lower risks for disease progression, compared with tamsulosin (P=0.006) or tamsulosin+naftopidil (P=0.028) patients. Multivariate analysis further showed that silodosin treatment in those with non-muscle-invasive tumor was associated with improved progression-free survival, compared with naftopidil (hazard ratio=0.086; 95% confidence interval=0.008-0.905; P=0.041) or tamsulosin/naftopidil (hazard ratio=0.128; 95% confidence interval=0.016-1.036; P=0.054) treatment. Our in vitro studies thus indicate that both urothelial tumorigenesis and tumor growth are inhibited by silodosin, but not by tamsulosin or naftopidil. Clinical data further suggest that even pharmacological doses (e.g. 0.1 µM) of silodosin contribute to preventing bladder cancer progression. 相似文献
993.
Kohei Saito Tatsuhide Inoue Hiroyuki Ariyasu Toshio Shimada Hiroshi Itoh Issei Tanaka Chikashi Terao 《Journal of diabetes investigation.》2022,13(4):706
Aims/IntroductionWe aimed to replicate a new diabetes subclassification based on objective clinical information at admission in a diabetes educational inpatient program. We also assessed the educational outcomes for each cluster.MethodsWe included diabetes patients who participated in the educational inpatient program during 2009–2020 and had sufficient clinical information for the cluster analysis. We applied a data‐driven clustering method proposed in a previous study and further evaluated the clinical characteristics of each cluster. We investigated the association between the clusters and changes in hemoglobin A1c level from the start of the education program. We also assessed the risk of re‐admission for the educational program.ResultsWe divided a total of 651 patients into five clusters. Their clinical characteristics followed the same pattern as in previous studies. The intercluster ranking of the cluster center coordinates showed strong correlation coefficients with those of the previous studies (mean ρ = 0.88). Patients classified as severe insulin‐resistant diabetes (cluster 3) showed a more pronounced progression of renal dysfunction than patients classified as the other clusters. The patients classified as severe insulin‐deficient diabetes (cluster 2) had the highest rate of reduction in hemoglobin A1c level from the start of the program (P < 0.01) and a tendency toward a lower risk of re‐admission for the education program (hazard ratio 0.47, P = 0.09).ConclusionWe successfully replicated the diabetes subclassification using objective clinical information at admission for the education program. In addition, we showed that severe insulin‐deficient diabetes patients tended to have better educational outcomes than patients classified as the other clusters. 相似文献
994.
995.
Yuichiro Yoshino Mikio Ohtsuka Masakazu Kawaguchi Keisuke Sakai Akira Hashimoto Masahiro Hayashi Naoki Madokoro Yoshihide Asano Masatoshi Abe Takayuki Ishii Taiki Isei Takaaki Ito Yuji Inoue Shinichi Imafuku Ryokichi Irisawa Masaki Ohtsuka Fumihide Ogawa Takafumi Kadono Tamihiro Kawakami Ryuichi Kukino Takeshi Kono Masanari Kodera Masakazu Takahara Miki Tanioka Takeshi Nakanishi Yasuhiro Nakamura Minoru Hasegawa Manabu Fujimoto Hiroshi Fujiwara Takeo Maekawa Koma Matsuo Osamu Yamasaki Andres Le Pavoux Takao Tachibana Hironobu Ihn The Wound/Burn Guidelines Committee 《The Journal of dermatology》2016,43(9):989-1010
Burns are a common type of skin injury encountered at all levels of medical facilities from private clinics to core hospitals. Minor burns heal by topical treatment alone, but moderate to severe burns require systemic management, and skin grafting is often necessary also for topical treatment. Inappropriate initial treatment or delay of initial treatment may exert adverse effects on the subsequent treatment and course. Therefore, accurate evaluation of the severity and initiation of appropriate treatment are necessary. The Guidelines for the Management of Burn Injuries were issued in March 2009 from the Japanese Society for Burn Injuries as guidelines concerning burns, but they were focused on the treatment for extensive and severe burns in the acute period. Therefore, we prepared guidelines intended to support the appropriate diagnosis and initial treatment for patients with burns that are commonly encountered including minor as well as moderate and severe cases. Because of this intention of the present guidelines, there is no recommendation of individual surgical procedures. 相似文献
996.
Analysis of treatment goal alignment between Japanese psoriasis patients and their paired treating physicians 下载免费PDF全文
Y. Okubo D. Tsuruta A.C. Tang S. Inoue H. Torisu‐Itakura T. Hanada M. Ohtsuki 《Journal of the European Academy of Dermatology and Venereology》2018,32(4):606-614
Background
Appropriate goal‐oriented treatment strategies are important for optimal treatment outcomes and may prevent under‐treatment. As treatment goals vary by patient, a study to examine treatment goals is more meaningful when patients and their physicians are paired. There has not been any study that examines alignment between paired psoriasis patients and physicians in real‐world clinical practice using skin clearance as a treatment goal indicator.Objectives
To evaluate treatment goal alignment between psoriasis patients and their paired physicians, and to quantitatively identify factors associated with goal misalignment.Methods
The study was a nationwide multicenter cross‐sectional observational study. Subjects were physician‐reported moderate‐to‐severe psoriasis patients with a history of systemic treatments, directly paired with their treating physicians. Subjects completed surveys independently. Treatment goals included seven categories, and patient–physician pairs were grouped as ‘aligned’ or ‘misaligned’ when the answers were the same or different, respectively.Results
A total of 425 pairs (mean response rate, 94.7%) of responses were collected from 54 sites (64.8% general practitioners or clinics; 35.2% university or large hospitals). Treatment goal misalignment was found in 67.9% of the patient–physician pairs. The misalignment was mainly ‘patient predominant’ (60.9%) indicating that patients had higher goals (‘complete clearance’) than physicians. In the multivariate logistic regression analyses, patients’ treatment expectation for ‘complete clearance’ [odds ratio (OR): 1.927; 95% confidential interval (CI): 1.232–3.016] and physician rating of ‘level of understanding on treatment options’ being low (OR: 1.552, 95% CI; 1.082–2.227) were significant factors for treatment goal misalignment.Conclusions
The majority of treatment goal misalignment was found between paired psoriasis patients and their treating physicians in Japan. The most important contributing factors to misalignment were patients’ treatment expectation for ‘complete clearance’ and physicians’ rating of their patients’ ‘level of understanding on treatment options’ being low. 相似文献997.
Takuwa Yasuda Toshiyuki Fukada Keigo Nishida Manabu Nakayama Masashi Matsuda Ikuo Miura Teruki Dainichi Shinji Fukuda Kenji Kabashima Shinji Nakaoka Bum-Ho Bin Masato Kubo Hiroshi Ohno Takanori Hasegawa Osamu Ohara Haruhiko Koseki Shigeharu Wakana Hisahiro Yoshida 《The Journal of clinical investigation》2016,126(6):2064-2076
Skin homeostasis is maintained by the continuous proliferation and differentiation of epidermal cells. The skin forms a strong but flexible barrier against microorganisms as well as physical and chemical insults; however, the physiological mechanisms that maintain this barrier are not fully understood. Here, we have described a mutant mouse that spontaneously develops pruritic dermatitis as the result of an initial defect in skin homeostasis that is followed by induction of a Th2-biased immune response. These mice harbor a mutation that results in a single aa substitution in the JAK1 tyrosine kinase that results in hyperactivation, thereby leading to skin serine protease overexpression and disruption of skin barrier function. Accordingly, treatment with an ointment to maintain normal skin barrier function protected mutant mice from dermatitis onset. Pharmacological inhibition of JAK1 also delayed disease onset. Together, these findings indicate that JAK1-mediated signaling cascades in skin regulate the expression of proteases associated with the maintenance of skin barrier function and demonstrate that perturbation of these pathways can lead to the development of spontaneous pruritic dermatitis. 相似文献
998.
Hitomi Sakurai Mitsuaki Suzuki Shoko Itakura Hiroaki Todo Florencio Arce Jr. Gerard Lee See Takashi Tanikawa Yutaka Inoue 《Materials》2022,15(8)
Ellagic acid (EA), a natural polyphenol found in berries, has high antioxidant capacity. This study aimed to improve EA solubility by complex formation with urea (UR) using solvent evaporation method and evaluate its solubility, antioxidant capacity, and physical properties. The solubility test (25 °C, 72 h) showed that the solubility of EVP (EA/UR = 1/1) was approximately two-fold higher than that of EA (7.13 µg/mL versus 3.99 µg/mL). Moreover, the IC50 values of EA and EVP (EA/UR = 1/1) (1.50 µg/mL and 1.30 µg/mL, respectively) showed higher antioxidant capacity of EVP than that of EA. DSC analysis revealed that the UR peak at 134 °C disappeared, and a new endothermic peak was observed at approximately 250 °C for EVP (EA/UR = 1/1). PXRD measurements showed that the characteristic peaks of EA at 2θ = 12.0° and 28.0° and of UR at 2θ = 22.0°, 24.3°, and 29.1° disappeared and that new peaks were identified at 2θ = 10.6°, 18.7°, and 26.8° for EVP (EA/UR = 1/1). According to 2D NOESY NMR spectroscopy, cross-peaks were observed between the -NH and -OH groups, suggesting intermolecular interactions between EA and UR. Therefore, complexation was confirmed in EA/UR = 1/1 prepared by solvent evaporation, suggesting that it contributed to the improvement in solubility and antioxidant capacity of EA. 相似文献
999.